Page 5 of Glenmark Pharmaceuticals

Buy these two stocks for gains; Nifty support visible at 17300-17150, Bank Nifty support at 36900

From the second week of October 21, momentum oscillator RSI (14) is reading in a lower low lower high formation…

April 18, 2022 08:04 IST

Sun Pharma, Glenmark, USFDA, health news, pharma news,

Glenmark receives DCGI nod to conduct clinical trials of its molecule on cancer patients

Glenmark Specialty SA has received approval from the DCGI to conduct a Phase 1 clinical trial of its novel small…

April 11, 2022 12:06 IST

Stocks to buy: Glenmark Pharma, NTPC shares may rally as much as 17% in next three months

ICICI Direct has picked the two stocks based on their delivery pick up in the last two weeks, historic volatility,…

April 8, 2022 13:24 IST

FE Pharma Summit, Sun Pharmaceutical, Zydus Cadila, Glenmark Pharmaceuticals, Biocon, DCGI

FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges

The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders…

Updated: March 23, 2022 15:05 IST

Glenmark Life Sciences listing: No bumper gains; shares debut at 4% premium to IPO price

Glenmark Life Sciences shares made a weak listing on the stock exchanges today, marred by the muted market momentum.

Updated: August 6, 2021 10:20 IST

Glenmark Life Sciences IPO subscribed 12.19 times so far; check grey market premium here

Glenmark Life Sciences initial public offering (IPO) has so far been subscribed 12.19 times, receiving a strong response from investors.

Updated: July 29, 2021 13:13 IST

Glenmark Life Sciences IPO caught amid pharma sell-off, grey market premium weak; should you subscribe?

Investors can bid for Glenmark Life Sciences IPO at the fixed price band of Rs 695 – 720 per share…

Updated: July 28, 2021 12:25 IST

Glenmark Life Sciences’ Rs 1,513.6-crore IPO fixes price band; check bid lot size, listing date, other details

Glenmark Life Sciences’ IPO will open for subscription on Tuesday, 27 July, at a price band of Rs 695-720 per…

July 21, 2021 10:24 IST

Glenmark Life Sciences IPO, Glenmark Pharma

Glenmark Life Sciences IPO opens July 27, IPO size reduced; plans to sell now 63 lakh shares via OFS

Glenmark Life Sciences’, a subsidiary of Glenmark Pharmaceuticals, IPO will open for subscription next week on 27 July and close…

July 20, 2021 14:30 IST

Glenmark Q4 net profit up 6 pc at Rs 233.87 cr

The company has in place strategic levers to grow its businesses sustainably, with a focus on strengthening its balance sheet,…

May 29, 2021 13:50 IST

Glenmark Life Sciences files IPO papers with SEBI; plans to sell over 73 lakh shares via OFS

Glenmark Life Sciences Ltd, a subsidiary of Glenmark Pharmaceuticals Ltd, filed a Draft Red Herring Prospectus (DRHP) with the capital…

April 17, 2021 12:48 IST

Glenmark Pharma share price jumps 7% today on upbeat April-June quarter results

Glenmark Pharma’s consolidated revenue stood at Rs 2,344.78 crore for the April-June quarter. The company had reported Rs 2,322.87 crore…

August 17, 2020 10:57 IST

Stocks in focus: Rossari Biotech, Glenmark Pharma, L&T, HDFC AMC, Vodafone Idea, Axis Bank

ABB India, Biocon, HDFC Asset Management Company, AU Small Finance Bank, Dish TV, Mphasis, PNB Housing Finance, Radico Khaitan, Sterlite…

July 23, 2020 08:57 IST

Glenmark Pharmaceuticals share price rallies 15% as firm launches COVID-19 drug Favipiravir

Glenmark Pharma stock has gained 180 per cent in less than three months from its 52-week low of Rs 168…

June 22, 2020 10:20 IST

U.S. Stocks, Apple, Stock Split, iPhone maker, U.S. tech companies, U.S. tech stocks

Stocks in focus: Glenmark Pharma, Cipla, Reliance Capital, HDFC Bank shares to remain in news today

Market sentiments would be swayed by global cues, development around geopolitical tensions, coronavirus cases, monthly F&O expiry and foreign fund…

June 22, 2020 08:54 IST

digihaler, digital dose inhaler, asthma patients, dose for asthma patients, asthma problems, digital inhaler, Glenmark

Glenmark launches digital dose inhaler for asthma patients

Glenmark Pharmaceuticals today launched ‘Digihaler’, the country’s first digital dose inhaler (DDI), for asthma and chronic obstructive pulmonary disease (COPD)…

May 25, 2016 18:49 IST

Glenmark records a 29.89 per cent growth in Q4 FY 15-16

India Business grew at 22.52 per cent to Rs 5,397.72 million for the quarter and to Rs 21,092.72 million for…

May 13, 2016 10:24 IST

Glenmark Pharma’s drugs gets tentative ANDA approval

The approvals are for norethindrone acetate and for adapalene and benzoyl peroxide gel

Updated: May 2, 2016 14:06 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

‘India proved everyone wrong’: IMF chief hails bold reforms, says country ’emerging as key engine of global growth’

Smart Investor’s Guide to Safe Investing Online

US visa rules, US visa policy, immigrant visa interview, nonimmigrant visa update, consular district interview, US embassy visa process, visa scheduling changes 2025, US travel regulations

US announces stricter visa interview rules for all immigrant and nonimmigrant applicants

‘SEVIS terminated’: F-1 OPT status ends abruptly as H-1B revoked, India student react

Indian Railways to develop dedicated passenger corridors, launch Vande Bharat 4.0

Railways7 min ago

Indian Railway Minister Ashwini Vaishnaw revealed a 30-year plan to create a Dedicated Passenger Corridor (DPC) to meet the increasing demand for passenger trains. The high-speed rail network, with speeds up to 350 kmph, will be exclusively for passengers and is inspired by the success of the Dedicated Freight Corridors (DFC). The DPC will also prioritize modernization and expansion efforts.

View all shorts